Real time management of data relating to physiological control of glucose levels
AssigneeAbbott Diabetes Care Inc.
InventorsCharles Wei, Gary Alan Hayter
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Diabetes Care Inc.
InventorsCharles Wei, Gary Alan Hayter
Estimating the term…
Continuous glucose monitoring (CGM) data and insulin delivery data are used to generate more reliable projected alarms related to a projected glucose levels. A memory stores endogenous data related to measurements of glucose level in a patient, and also stores exogenous data, such as insulin on board, both of which are used by a processor to create projected alarms. Profiles of CGM data are created for use in tuning patient-specific insulin data, such at basal rate, carb ratio, and insulin sensitivity. A processor searches for patterns in the data profiles and if found, recommended changes to patient-specific insulin data are provided to permit more accurate control over a patient's glucose levels.
An integrated glucose management system for treating diabetes of a patient, the system comprising:
A method of treating diabetes, comprising:
An integrated glucose management system for treating diabetes of a patient, the system comprising:
Dependencies are inferred from the claim text.